Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Cyanovirin-N

From Wikipedia, the free encyclopedia
Protein
This article mayrequirecleanup to meet Wikipedia'squality standards. The specific problem is:Spelling, Grammar, Style, Repeating & Unsourced Content. Please helpimprove this article if you can.(October 2017) (Learn how and when to remove this message)

Cyanovirin-N (CV-N) is aprotein produced by thecyanobacteriumNostoc ellipsosporum that displaysvirucidal activity against severalviruses, includinghuman immunodeficiency virus (HIV).[1] A cyanobacterial protein called cyanovirin-N (CV-N) has strong anti-human immunodeficiency virus (HIV) neutralizing properties.[2] The virucidal activity of CV-N is mediated through specific high-affinity interactions with theviral surface envelopeglycoproteinsgp120 and gp41, as well as high-mannoseoligosaccharides found on the HIV envelope.[3] In addition, CV-N is active againstrhinoviruses,humanparainfluenza virus,respiratory syncytial virus, andenteric viruses. The virucidal activity of CV-N againstinfluenza virus is directed towards viralhaemagglutinin.[4]

The blue-green algaNostoc ellipsosporum naturally contains CV-N. The National Cancer Institute (NCI) in the United States of America carried out the initial isolation and characterization of this protein in 1999.[5] The use of CV-N as an antiviral drug, particularly against HIV, has since been the subject of investigation. Its ability to bind to the HIV-encapsulating glycoprotein gp120 has been demonstrated in several studies, which has led to the development of CV-N-based therapies and preventatives.[5]

Structure

[edit]

CV-N is a lengthy, mostly beta-sheet protein that displays internal two-fold pseudosymmetry. The fundamental atomic root-mean-square of the two sequence repeats (1-50 and 51-101) differs by 1.3 A while sharing 32% of the same sequence. The total fold depends on a number of interactions between the two repetitions, therefore, they do not actually belong in separate domains.[6] CV-N has a complex fold of atandem repeat duplication of twohomologousmotifs, comprising three-strandedbeta-sheet and beta-hairpins.[7]

References

[edit]
  1. ^Zappe H, Snell ME, Bossard MJ (2008). "PEGylation of cyanovirin-N, an entry inhibitor of HIV".Adv. Drug Deliv. Rev.60 (1):79–87.doi:10.1016/j.addr.2007.05.016.PMID 17884238.
  2. ^Dey, Barna, Danica L. Lerner, Paolo Lusso, Michael R. Boyd, John H. Elder, and Edward A. Berger. “Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses.” Journal of Virology 74, no. 10 (2000): 4562–69.https://doi.org/10.1128/jvi.74.10.4562-4569.2000.)
  3. ^Botos I, Wlodawer A (February 2003)."Cyanovirin-N: a sugar-binding antiviral protein with a new twist".Cell. Mol. Life Sci.60 (2):277–87.doi:10.1007/s000180300023.PMC 11138712.PMID 12678493.S2CID 10579615.
  4. ^O'Keefe BR, Smee DF, Turpin JA, Saucedo CJ, Gustafson KR, Mori T, Blakeslee D, Buckheit R, Boyd MR (August 2003)."Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin".Antimicrob. Agents Chemother.47 (8):2518–25.doi:10.1128/aac.47.8.2518-2525.2003.PMC 166092.PMID 12878514.
  5. ^abBoyd, MR; Gustafson, KR; McMahon, JB; Shoemaker, RH; O'Keefe, BR; et al. (June 1997)."Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development".Antimicrobial Agents and Chemotherapy.41 (6):1521–1530.doi:10.1128/AAC.41.7.1521.PMC 163952.PMID 9210678.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  6. ^Bewley, C.; Gustafson, K.; Boyd, M.; Covell, D.G.; Bax, A.; Clore, G.M.; Gronenborn, A.M. (1998). "Solution structure of cyanovirin-N, a potent HIV-inactivating protein".Nature Structural and Molecular Biology.5 (7):571–578.doi:10.1038/828.PMID 9665171.S2CID 11367037.
  7. ^Botos I, O'Keefe BR, Shenoy SR, Cartner LK, Ratner DM, Seeberger PH, Boyd MR, Wlodawer A (September 2002)."Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides".J. Biol. Chem.277 (37):34336–42.doi:10.1074/jbc.M205909200.PMID 12110688.

External links

[edit]
Capsid inhibitors
Entry/fusion inhibitors
(Discovery and development)
Integrase inhibitors
(Integrase strand transfer inhibitors (INSTI))
Maturation inhibitors
Protease Inhibitors (PI)
(Discovery and development)
1st generation
2nd generation
Reverse-transcriptase
inhibitors
(RTIs)
Nucleoside and
nucleotide (NRTI)
Non-nucleoside (NNRTI)
(Discovery and development)
1st generation
2nd generation
Combined formulations
Pharmacokinetic boosters
Experimental agents
Uncoating inhibitors
Transcription inhibitors
Translation inhibitors
BNAbs
Other
Failed agents
°DHHSrecommendedinitial regimen options.Formerly or rarely used agent.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Cyanovirin-N&oldid=1270707268"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp